Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|July 20, 2017
Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Computers in Biology and Medicine|November 22, 2023
PmxPred: A data-driven approach for the identification of active polymyxin analogues against gram-negative bacteriaXiaoyu Wang, Nitin Patil, Fuyi Li, et al.
British Journal of Haematology|May 11, 2021
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemiaHua-Jay J Cherng, Nadya Jammal, Shilpa Paul, et al.
Respiratory Medicine|June 30, 2018
Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthmaNadia Nicholine Poulsen, Asger Bjerregaard, Siew-Kim Khoo, et al.
Respiration; International Review of Thoracic Diseases|June 20, 2015
Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis BronchiectasisDomagoj A Vodanovich, Thomas J Bicknell, Anne E Holland, et al.
British Journal of Clinical Pharmacology|June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiencyMichael A Tortorici, James A Rogers, Oliver Vit, et al.
Molecular Cancer Research : MCR|January 29, 2017
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 ComplexUri Rozovski, David M Harris, Ping Li, et al.
American Journal of Hematology|May 14, 2022
TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysisHua-Jay J Cherng, Raamis Khwaja, Rashmi Kanagal-Shamanna, et al.
BMJ Open|October 25, 2011
Clinical and epidemiological profile of patients with severe H1N1/09 pandemic influenza in Australia and New Zealand: an observational cohort studyAllen C Cheng, Tom Kotsimbos, Anna Reynolds, et al.
Cancer|May 4, 2018
Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemiaKiran Naqvi, Elias Jabbour, Jeffrey Skinner, et al.
Pageof 6